ArticleJournal of ovarian research2025

Pretreatment with oral contraceptives benefit POSEIDON group 1 low prognosis patients during GnRH-antagonist protocol: a propensity score-matched retrospective cohort study.

Ning Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.